Australia's Amplia Therapeutics falls on discounted capital raising
** Shares of Amplia Therapeutics ATX.AX fall as much as
14.1% to A$0.073, set for worst day since March 13 - if current
trend holds
** Drug developer undertakes entitlement offer to raise
A$4.27 mln ($2.74 mln)
** Co says capital raising at issue price of A$0.055 per new
share, a 35.3% discount to the stock's last closing price
** Stock had risen more than 6% this year, as of last close
($1 = 1.5567 Australian dollars)
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com;))
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement